Boao Lecheng Explained: China’s Only Medical Special Zone (2026)

Somewhere on Hainan island there’s a place that doesn’t work like the rest of China’s medical system. Boao Lecheng International Medical Tourism Pilot Zone is the country’s only “medical special zone” — a government-designated area where innovative drugs and devices approved abroad but not yet available on the Chinese mainland can be legally prescribed and used under a special framework.

For a foreign visitor — or anyone researching advanced care in China — this is worth understanding, because it changes the answer to a deceptively simple question: “What treatments can I actually get in China, and where?” Here’s a plain-English explainer. (This is an informational guide — not medical advice.)

The One-Line Summary

Boao Lecheng is China’s fast-track: if a medicine or device is already approved by a major international regulator (U.S. FDA, EU CE-mark, etc.) but hasn’t finished China’s multi-year national approval process, it can be legitimately used inside the Lecheng zone. Overseas drugs can be specially imported for patients there — no waiting out the usual 3-8 year registration marathon.

Why It Exists: The Problem Lecheng Solves

Normally, a new drug proven safe and effective overseas must go through years of Chinese regulatory review before patients can use it. For someone with a serious condition where the standard options have plateaued, that wait can be brutal.

Lecheng was created to cut that gap. Under its “pioneering pilot” policy, approved medical institutions inside the zone can introduce and clinically apply innovative drugs and devices cleared by major international regulators — before full approval by China’s National Medical Products Administration (NMPA). Policies covering special medical treatment, research, operations, and international medical exchange — more than 50 pilot measures in all — support it. (Hainan govt, Oct 2026)

The result is a “both ways” bridge: international innovation enters China faster, and China’s clinical data accelerates those same products’ approval globally.

The Numbers (2026)

The scale demands attention:

• 791,300 medical-tourist visits to Lecheng in the first eight months of 2026, up 98.97% year on year.
• 9,611 overseas medical tourists in the same period, a 4.5-fold increase, from more than 20 countries.
• 620+ specially-approved drugs, devices and special foods introduced, covering 41 clinical disciplines — oncology, cardiology, hematology, ophthalmology, pediatrics and more.
• 340,000+ patient visits have benefited from these products to date.
• 43 hospitals and medical institutions operate in the zone, mixing leading public hospitals with specialty private and premium international facilities.

Sources: Hainan Health Commission, Oct 2026; Hainan govt, Oct 2026.

What Make It Special: The Four Key Pillars

1. Special drugs & devices access. Institutions in the zone can import and use overseas-approved products not yet on the mainland. French and EU-approved minimally-invasive laser systems, rare-disease drugs, CAR-T-class cell therapies — the catalog spans oncology, rare disease, cardiovascular, ophthalmology, orthopedics and more. By Jan 2026, 182 authorized drugs had been administered across 15 clinical departments, and 19 approved cell/gene therapy options were available. (CGTN, Apr 2026; Lecheng Medical, Jan 2026)

2. Real-world data → faster national approval. Lecheng pioneered “real-world evidence”: clinical data generated from real patient use inside the zone can be used as key evidence toward national registration. 26 specially-approved products have leveraged this channel to accelerate approval for national use, with 5 already incorporated into China’s national insurance/commercial-insurance catalogs. (Hainan govt, Oct 2026; Hainan govt, May 2026)

3. Special foods & health products. Lecheng is the country’s only region where legally-marketed overseas dietary/health foods and certain nutritional formulas can be temporarily imported — 16 special foods including nutritional formula for rare conditions like Crohn’s (previously unavailable on the mainland). Visitors even buy approved health supplements as Hainan souvenirs. (Hainan govt, Oct 2026)

4. Payment innovation. Lecheng pioneered the Boao Lecheng Global Special-Medicine Insurance (2020) — the first product letting mainland patients get reimbursement for overseas-approved drugs. It has iterated and now covers 24 rare-disease special drugs, reaching 116 million people cumulatively. The zone is also pairing cutting-edge therapies with custom commercial-insurance models (e.g., BNCT cancer therapy), lowering out-of-pocket barriers. (Hainan Daily, May 2026)

Should a Foreign Visitor Consider It?

Lecheng is genuinely relevant to two groups of international patients:

• Those seeking care not (yet) available on the mainland — if a drug or therapy you need is approved overseas but not in China, Lecheng is the designated place where it may be legitimately accessible.
• Those combining advanced care with a trip — located in Qionghai, Hainan, the zone sits in a tropical resort province with relatively open visa-free entry (verify your nationality) and integrates care with coastal tourism and Qionghai’s rural-wellness scene.

But it’s not a walk-in. Access is channeled through the zone’s accredited hospitals, requires a preliminary eligibility assessment with your records, and costs vary substantially by therapy (some advanced cell/gene treatments run into the hundreds of thousands of RMB; that’s a real, personal financial decision to discuss with the treating team and your insurer). See our Hainan medical tourism guide for the practical travel layer.

Honest Caveats

• Not a shortcut around assessment. Every product is subject to rigorous expert review and your eligibility depends on your actual medical records and a clinical consult — not on a brochure.
• Costs are case-by-case. Package/package pricing for standard check-ups exists; advanced therapies are individually quoted and can be expensive. Get written estimates before committing.
• Insurance is evolving but situational. The special-medicine insurance and insurer partnerships reduce friction, but you should confirm coverage and reimbursement for your plan and your intended treatment directly.
• Not medical advice. This explainer helps you understand the system; whether any given drug or therapy fits your case is for the treating clinicians to decide.

Going Deeper

• New to TCM and want to see how Chinese medicine fits alongside all this? Start with our TCM first-timers guide.
• Planning the practical trip? See How to book a hospital & arrange a visa in China — booking, documentation and entry in one place.
• Want the full Hainan picture? Our Hainan medical tourism guide covers Sanya wellness, check-ups and itineraries.

Bottom line: Boao Lecheng is one of the most genuinely novel things in global medical tourism — a legally-sanctioned special zone where the world’s newest therapies can meet patients before China’s national queue clears. If you’re researching advanced or rare-disease care and wondering where in China cutting-edge treatments are actually accessible, Lecheng is where that answer starts.

Anchsia note: This is an informational guide for foreign visitors to China, not medical advice. Policies, product availability, costs and eligibility change; verify everything directly with accredited Lecheng institutions, your insurer and official sources before deciding.